Effects of fibronectin and type IV collagen on osteosarcoma cell apoptosis.
Indian J Exp Biol
;
2013 Oct; 51(10): 789-796
Artículo
en Inglés
| IMSEAR
| ID: sea-149383
ABSTRACT
The aims of this study are the investigation of the effects of fibronectin and type IV collagen extracellular matrix proteins and the role of caspase-3 and -9 on cis-platin induced U2-OS apoptosis were studied. First the cytotoxic effects of cis-platin on cell system were investigated by colorimetric method and than morphological and ELISA analysis were used for determination of cell apoptosis when induced with cis-platin. In addition, after adhering the cells to fibronection or type IV collagen proteins, the apoptotic rate and the effects of caspase-3 and -9 were also investigated by ELISA in presence of specific inhibitors. U2-OS cells showed 20% cytotoxicity after treatment with 2.4 µM of cis-platin for 48 h. Morphological and the numerical data showed that cis-platin was able to induced apoptosis on cells as a dose-dependent manner. Caspase-3 and -9 inhibitors inhibited cis-platin-induced apoptosis in U2-OS cells, respectively. The binding of cells to 10 µg/mL of fibronectin but not type IV collagen enhanced the apoptosis about 2.5 fold that effects inhibited with caspase-3 inhibitor. The caspase-3 and -9 are involved in the apoptotic signals induced by cis-platin in U2-OS. The binding to fibronectin, but not type IV collagen enhanced the apoptotic response of U2-OS and fibronectin-dependent apoptosis was activated by caspase-3. These finding might be useful for patients to fight against osteosarcoma.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Neoplasias Óseas
/
Humanos
/
Osteosarcoma
/
Fibronectinas
/
Cisplatino
/
Apoptosis
/
Colágeno Tipo IV
/
Línea Celular Tumoral
/
Relación Dosis-Respuesta a Droga
/
Evaluación Preclínica de Medicamentos
Idioma:
Inglés
Revista:
Indian J Exp Biol
Año:
2013
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS